🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The BNT16B2B mRNA vaccine trial is out in NEJM. Very efficacious and safe across multiple subgroups ! OncoAlert COVID-19 and Cancer Consortium (CCC19) Registry Vincent Rajkumar KizzyPhD nejm.org/doi/10.1056/NE…

Proud of Aeen Asghar MD & our mutiinstitutional CORRUS database Temple Urology NYU Langone Urology @HUMGUrology for publishing on Robotic Ureteral Recon in Pts with/Radiation-Induced Strictures pubmed.ncbi.nlm.nih.gov/32814443/ and making Journal of Endourology Feb2021 cover! Pushing boundaries Temple Med School

The CURES Act is harmful to patients and ruining the patient-doctor relationship. When a patient gets an alert on their cell they have cancer before their doctor can have a conversation with them, who does that help? Congress fix this! Pat Toomey (US Sen. ret.) Bob Casey Mary Gay Scanlon

Fox Chase's Dr. Phillip Abbosh (@scientistatlrge) has been awarded an NIH grant to develop a urine test that can detect #bladdercancer. Its potential for higher sensitivity is promising and may also spare some patients a cystectomy. Read more: bit.ly/3ySVOru

I will be traveling to Polish and Ukrainian border to assist refugees , majority women and children . Providing medical and urgent assistance to everyone . Please donate EVERY single penny will go towards our efforts … please retweet facebook.com/clevelandmaida… Amer. Urol. Assn.

They are worth high #gasprices. #IStandWithUkraine

📣Excited to announce a 1-yr GU reconstruction fellowship NM Urology Offering a unique experience: -High volume📈 -Ample research opportunities🔬 -Emphasis on complex robotic recon of the upper/lower urinary tracts🤖 Accepting applications for July 2023 DM me for more info!

71% response with median duration of response of 2 years for BCG unresponsive CIS patients receiving N-803. Also fantastic response for papillary patients. Presented by Karim Chamie UCLA Urology Extremely well-tolerated. #aua22 #bladdercancer

Neeraj Agarwal, MD, FASCO JAMA Oncology OncoAlert UroToday.com Matt Cooperberg GU Cancer Research Program @HuntsmanCancer Daniel Castellano Gianluca Giannarini Arun Azad Simon C Andrey Soares Sumanta K. Pal, MD, FASCO Nicolas Sayegh, MD Bogdana Schmidt MD, MPH Aakash Desai, MD, MPH, FASCO On first reading, this is totally nuts!!! On second reading, still nuts! Thankfully, this will not be practice-changing. AS is not broken, certainly doesn’t need paradoxical oxymoronic enhancement by adding enzalutamide! GU Cast will dissect next week Renu Eapen

A good read on the modern thought process behind management of pyeloplasty failures. Endopyelotomy is out and buccal grafting is in. Great job helping me to write this up Matthew Lee!

Stay tuned for the first Annual Christopher G Wood Urologic Oncology Symposium March 30-April 2, 2023 in Austin TX Sponsored by University of Texas System: MD Anderson Cancer Center UTSouthwestern.org UTSA UTMB Health UT Austin Chris Wood

"Cystic" on imaging ≠ cystic pathology > 80% of radiographic Bosniak lesions are not described as "cystic" on path >1 in 5 resected cystic renal lesions harbor HG disease Yet, AS very safe Read latest from Randall Lee MD Fox Chase Cancer Center Department of Urology pubmed.ncbi.nlm.nih.gov/36630588/ Journal of Urology

“Our success is predicated on your success” CGW

Do you close the mesenteric defect during cystectomy/ileal conduit? This RCT says we should! Reoperation rate for SBO reduced by 58% if defect is closed! #bladdercancer #UroSoMe #MedEd Mesenteric Defects Closure in Laparoscopic Gastric Bypass Surgery jamanetwork.com/journals/jamas…

The Univ. of Texas, Christopher G Wood Advances in Urologic Oncology Symposium April 12-14, 2024 Omni Barton Creek, Austin Great venue and amazing collaboration of programs Mark your calendars! #oncsurgery MD Anderson Cancer Center @UTSWNews UTMB Health University of Texas Houston Urology UT Austin UTSA

Truly a wonderful place to train. Still thankful every day that I got to learn from these guys!

We were lucky to enjoy a thought provoking and engaging series of lectures from our VP Scott Eggener this week. Great to be challenged to think critically about dealing with complications and embracing change in classifying low risk CaP. A great guy and decent pickleball player!

Powerhouse training 💪 in a phenomenal city! 🌆Temple Urology Fox Chase Cancer Center Department of Urology 

“From Fellowship to faculty” UT fellow alumni presenting cases to the#UTCGW symposium. Proud of these fine docs and love the opening by Dan Shapiro, roasting all the faculty from MD Anderson Cancer Center #oncsurgery